Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
The current price of PCRX.BOATS is $22.74 USD — it has increased by +0% in the past 24 hours. Watch Pacira BioSciences stock price performance more closely on the chart.
What is Pacira BioSciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pacira BioSciences stocks are traded under the ticker PCRX.BOATS.
What is Pacira BioSciences market cap?▼
Today Pacira BioSciences has the market capitalization of 920.74M
When is the next Pacira BioSciences earnings date?▼
Pacira BioSciences is going to release the next earnings report on May 06, 2026.
What were Pacira BioSciences earnings last quarter?▼
PCRX.BOATS earnings for the last quarter are 0.57 USD per share, whereas the estimation was 0.9 USD resulting in a -37.01% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pacira BioSciences revenue for the last year?▼
Pacira BioSciences revenue for the last year amounts to 1.45B USD.
What is Pacira BioSciences net income for the last year?▼
PCRX.BOATS net income for the last year is 14.07M USD.
When did Pacira BioSciences complete a stock split?▼
Pacira BioSciences has not had any recent stock splits.